Edra
European Annals of Allergy and Clinical Immunology THE OFFICIAL JOURNAL OF AAITO THE OFFICIAL JOURNAL OF SPAIC HOME PAGE
2022 Impact Factor
2.3
EDITORS IN CHIEF
M. B. Bilò (Italy)
P. Carreiro-Martins (Portugal)

DEPUTY EDITORS
R. Rodrigues Alves (Portugal)
D. Villalta (Italy)
 
ASSOCIATE EDITORS
R. Asero (Italy)
M. Branco Ferreira (Portugal)
L. Cecchi (Italy)
E. Scala (Italy)
D. Solé (Brasil)
G. Sturm (Austria)

EDITORIAL BOARD
I. Agache (Romania)
I. Annesi Maesano (France)
L. Antonicelli (Italy)
G. Azizi (Iran)
L.M. Borrego (Portugal)
K. Brockow (Germany)
S. Bavbek (Turkey)
E. Cichocka-Jarosz (Poland)
M. Cugno (Italy)
L. Delgado (Portugal)
P. Demoly (France)
G. D'Amato (Italy)
S. Durham (UK)
M. Faber (Belgium)
M. Fernandez-Rivas (Spain)
J. Fonseca (Portugal)
ZS. Gao (China)
G.P. Girolomoni (Italy)
E. Goudouris (Brasil)
A. Grumach (Brasil)
G. Kostantinou (Greece)
F. Levi-Shaffer (Israel)
M. Maurer (Germany)
L. Mayorga (Spain)
C. Micheletto (Italy)
M. Morais de Almeida (Portugal)
G. Moscato (Italy)
A. Musarra (Italy)
C. Nunes (Portugal)
M. Ollert (Lussemburgo)
P. Parronchi (Italy)
G. Passalacqua (Italy)
E. Pedro (Portugal)
A. Perino (Italy)
O. Quercia (Italy)
A. Romano (Italy)
G. Scadding (UK)
A. Todo Bom (Portugal)
A. Tedeschi (Italy)
R. van Ree (Netherland)
S. Voltolini (Italy)

FOUNDERS
F. Bonifazi (Italy)
A. Sabbah (France)
************************* 

Chief Executive Officer 
Ludovico Baldessin

Editorial Coordinator
Barbara Moret

Publishing Editor
Jessica Guenzi
j.guenzi@lswr.it

Sales
dircom@lswr.it

EDRA SpA 
Via G. Spadolini, 7
20141 Milano - Italy
Ph. 0039 (0)2-88184.1
Fax 0039 (0)2-88184.301
www.edraspa.it


Follow us on LinkedIn



European Annals of Allergy and Clinical Immunology ISSN 1764-1489

© 2024

Online first Abstracts


Note to users


3/5/2023
LETTER TO THE EDITOR
Standard dose paracetamol-induced tubulointerstitial nephritis

Katherine Pose katherine.pose@salud.madrid.org1, Margarita Tomás-Perez1,2



28/3/2023
ORIGINAL ARTICLE
The impact of a drug allergy label in an internal medicine ward

Pedro Simão Coelho pedro.coelho3@chlc.min-saude.pt1, Gonçalo Martins dos Santos1, Mila Mikovic1, João Oliveira2, Sónia Rosa1, Eduardo Silva2, Paula Leiria Pinto1



28/3/2023
ORIGINAL ARTICLE
A real-world characterization of a cohort with eosinophilic esophagitis: looking for severity biomarkers

Leonor Esteves Caldeira leonorfsecaldeira@gmail.com1,*, Rita Limão1,*, Rita Brás1, Elisa Pedro1, Célia Costa dra.celiacosta.73@gmail.com1,2,*



16/3/2023
LETTER TO THE EDITOR
Hypersensitivity reactions to iron products: 10-year experience in a Portuguese tertiary Centre

Cláudia Varandas varandas@campus.ul.pt1, Josefina Vieira1, Catarina Jacinto Correia2, Marisa Paulino1, Amélia Spínola Santos1,3, Anabela Lopes1,3, Susana Lopes Da Silva1,3, Elisa Pedro1,3, Joana Caiado1,3



16/3/2023
ORIGINAL ARTICLE
A real life cohort of Mepolizumab treatment in severe eosinophilic asthma

Daniel Laorden laordendaniel1@gmail.com1, Irene Hernández2,3, Javier Domínguez-Ortega2, David Romero1, Rodolfo Álvarez-Sala1, Santiago Quirce2



2/3/2023
ORIGINAL ARTICLE
Factors effecting natural course of egg allergy

Handan Duman Şenol dumanhandan@yahoo.com, Mehmet Geyik, Ezgi Topyıldız, Ayşe Aygün, Figen Gülen, Esen Demir



14/2/2023
ORIGINAL ARTICLE
Immunological and molecular study in children with combined immunodeficiency

Shams Kholoussi1, Abeer Ramadan2, Naglaa Kholoussi1, Engy A. Ashaat3, Alaaeldin G Fayez2, Haiam Abdel Raouf1, Iman Helwa1, Nora N Esmaiel2, Raghda Ghorab1, Assem M. Abo-Shanab asem_nrc@yahoo.com1



14/2/2023
CASE REPORT
Ultrafast regimen for Pru p3 sublingual immunotherapy (SLIT-Peach®) in patients with anaphylactic LTP-Syndrome

Maria Soledad Zamarro Parra, Yulia Petryk Petryk, Javier Carbonell Zamorano, Antonio Carbonell Martinez med018934@gmail.com



13/2/2023
LETTER TO THE EDITOR
Clinical characterization of peach allergic patients and respective molecular sensitization profile with ALEX®2 macroarray

Maria Inês T. Silva inescerca92@gmail.com 1,2, Rita Brás1,2, Marisa Paulino1, Fátima Cabral Duarte1, Maria Conceição Pereira Santos2,3, Célia Costa1,3



13/2/2023
LETTER TO THE EDITOR
Atopic status and thyroid autoimmunity do not predict omalizumab response in severe CSU patients

Riccardo Asero r.asero@libero.it



  1  |  2  |  3  |  4  |  5  |  6  |